Mar 14 |
Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares
|
Mar 11 |
Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares
|
Mar 11 |
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
|
Feb 28 |
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
|
Feb 27 |
Apellis Pharmaceuticals, Inc. (APLS) Q4 and Full Year 2023 Earnings Call Transcript
|
Feb 27 |
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Earnings: What Key Metrics Have to Say
|
Feb 27 |
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
|
Feb 27 |
Apellis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 27 |
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Lags Revenue Estimates
|